Explore our blogs on various markets
-
7 Go-to-Market Strategies for Biosimilars Success
Biosimilars are medicines that are very close to already approved biologic drugs. They are not exact copies, but they work in the same way and are proven safe and effective. Because they cost less than original biologics, biosimilars help reduce healthcare spending and allow more patients to get access to important treatments....
-
8 Strategies for Successful Pharma Product Launches (2025)
Strategies for Successful Pharma Product Launches. Launching a new pharma product is not easy. It takes years of research, large investments, and strict regulatory approvals...
-
Health Equity in Pharma: Why It Matters and How to Act?
Health equity means everyone gets the care they need to live a healthy life. It means care and medicines reach people no matter their race, age, money, or where they live.. Right now, many people do not get fair care...
-
Future of Pharma Demand: Forecasting Models Explained
Accurate drug demand forecasting is the key to keeping medicines available and avoiding waste. It helps companies plan production, manage supply chains, and meet patient needs on time.. The future of drug demand is shaped by many factors, such as aging populations, new diseases, patent expiries, and personalized medicine...
-
Beyond Air Seeks FDA Nod for Next-Gen LungFit PH II
Beyond Air, Inc. (NASDAQ: XAIR) has submitted a premarket approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) for its second-generation LungFit PH II system....
-
FDA Approves First Treatment for Non-Cystic Fibrosis Bronchiectasis
The U.S. Food and Drug Administration (FDA) has approved BRINSUPRI™ (brensocatib), making it the first and only therapy for non-cystic fibrosis bronchiectasis (NCFB). . This chronic lung disease affects more than 500,000 people in the United States and has long been without an approved treatment option....
-
4 Launch Strategies for Cell and Gene Therapies
Cell and gene therapies (CGTs) represent a new frontier in healthcare. These treatments aim to modify or replace cells and genes to treat or cure diseases that were previously untreatable. . While their promise is enormous, launching them is not simple...
-
CRO Outsourcing Models for US Oncology Trials
Running oncology clinical trials in the US is complex and resource-heavy. Patient recruitment, biomarker testing, data collection, and regulatory reporting all demand specialized expertise. Pharmaceutical companies and biotech sponsors often rely on Contract Research Organizations (CROs) to manage parts or all of the trial process....
-
Global Pharma Regulations 2025: Key Trends Shaping Strategy
Regulation shapes every part of the pharmaceutical industry. Agencies like the WHO, FDA (US), EMA (EU), MHRA (UK), ANVISA (Brazil), NMPA (China), and CDSCO (India) control how drugs are researched, developed, manufactured, and approved.. In 2025, these authorities are updating their frameworks to keep pace with artificial intelligence, digital health, advanced clinical trial models, sustainability rules, and global supply chain standards....
-
Behavioural Science in Pharma Marketing (Explained)
Pharma companies spend billions every year trying to influence doctors, patients, and healthcare systems. Yet clinical data and product claims alone often fail to change outcomes. People rely on habits, emotions, social cues, and mental shortcuts, not just logic. ...